NR4A1 and breast carcinoma: Hormone receptor-positive breast cancer were relatively advanced cases of early breast cancer that require chemotherapy, whereas hormone receptor-negative breast cancer was excluded if the cancer is so small that NAC is not required, as well as elderly patients or patients with comorbidities who cannot tolerate NAC.